LRVHealth, McKesson Ventures, Novartis, Hearst Ventures, Onco360, and HealthX Ventures Join Investment Round to Redefine Specialty Patient Access and Onboarding
RxLightning, creator of the industry’s first comprehensive platform for streamlining specialty medication access and affordability,…
What You Should Know:
Cala, the bioelectronic medicine leader setting a new standard of care for chronic disease, today announced the commercial launch of its next generation therapy: the Cala kIQ™ System, the first and only…
Continue Reading
UK-based digital health tech company Huma has received FDA 510(k) Class II clearance for its configurable disease-agnostic Software as a Medical Device platform, which includes the company’s cardiovascular risk score algorithm. The company, which received…
Continue Reading
GE Healthcare has obtained FDA clearance for its DL model, Sonic DL, designed for cardiac MRI. This deep learning-enhanced technology enables the acquisition of high-quality MRI images up to 12 times faster than traditional…
Continue Reading
When regulators speak, we listen.
Naturally risk-averse industries like the life sciences need health authority acceptance before trying new approaches and especially before committing to wholesale operational change, even if the outcome has great potential….
GE Healthcare announced that the U.S. Food and Drug Administration has cleared Sonic DL, which leverages a neural network to accelerate image acquisition in magnetic resonance imaging, for healthcare use. WHY IT MATTERS
The need for…
Huma Therapeutics has received US Food and Drug Administration (FDA) Class II clearance for its disease-agnostic Software-as-a-Medical-Device (SaMD) platform, enabling companies to launch their own algorithm innovations more quickly to the platform and allowing…
Continue Reading
David Barzilai, VP of Sales and Marketing at Karamba Security
There is a fine line that connects the cars we drive and the medical devices we occasionally use. Both connect to the internet, and as…
Continue Reading
Welcome to our Healthcare IT Today Weekly Roundup. Each week, we’ll be providing a look back at the articles we posted and why they’re important to the healthcare IT community. We hope this gives…
Continue Reading
Cue Health has received FDA de novo authorization for its at-home COVID-19 test, becoming the first company to achieve this milestone. The test, called Cue COVID-19 Molecular Test, can detect genetic material from the…
Continue Reading
